Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging

Journal of Magnetic Resonance Imaging

Volumn 11, Issue 6, 2000, Pages 575-585

  Zhu, X P ^a   Li, K L ^a   Kamaly Asl, I D ^a   Checkley, D R ^b   Tessier, J J L ^b   Waterton, J C ^b   Jackson, A ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Angiogenesis; Brain neoplasms; Endothelial permeability; Perfusion; T1 and T2* relaxation; Vascular input function

Indexed keywords

ACOUSTIC NEURINOMA; ADULT; AGED; ARTICLE; BLOOD VOLUME; BRAIN TUMOR; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; GLIOMA; HUMAN; IMAGE QUALITY; MALE; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR BLOOD FLOW;

ADULT; AGED; BLOOD VOLUME; BLOOD-BRAIN BARRIER; BRAIN; BRAIN NEOPLASMS; CELL MEMBRANE PERMEABILITY; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; ENDOTHELIUM, VASCULAR; FEMALE; GLIOMA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MENINGIOMA; MIDDLE AGED; MODELS, THEORETICAL; NEUROMA, ACOUSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0034038538     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/1522-2586(200006)11:6<575::AID-JMRI2>3.0.CO;2-1     Document Type: Article

References (59)

1. Luthert PJ, Deane BR, Greenwood J, Pratt OE, Lantos PL. The vasculature of experimental brain tumours: angiogenesis, vascular pathology, and permeability studies. In: Walker MD, Thomas DGT, editors. Biology of brain tumour. Boston: Martinus Nij; 1986. p 197-202.
2. Folkman J. What is the evidence that tumours are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
3. Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T, Papadakis N, Varakis I. Microvessel density in brain tumors. Anticancer Res 1997;17:4747-4753.
4. Costello PC. Human cerebral microvascular endothelial involvement in neovascularization of malignant glial tumors. Diss Abstr Int [B] 1994;54:5543.
5. Lund EL, Spang-Thomsen M, Skovgaard-Poulsen H, Kristjansen PE. Tumor angiogenesis - a new therapeutic target in gliomas. Acta Neurol Scand 1998;97:52-62.
6. Damert A, Machein M, Breier G, et al. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res 1997;57:3860-3864.
7. Damert A, Ikeda E, Risau W. Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem J 1997;327:419-423.
8. Amoroso A, Del Porto F, Di Monaco C, Manfredini P, Afeltra A. Vascular endothelial growth factor: a key mediator of neoangiogenesis. A review. Eur Rev Med Pharmacol Sci 1997;1:17-25.
9. Dietzmann K, von Bossanyi P, Warich-Kirches M, et al. Immunohistochemical detection of vascular growth factors in angiomatous and atypical meningiomas, as well as hemangiopericytomas. Pathol Res Pract 1997;193:503-510.
10. PietschT, Valter MM, Wolf HK, et al. Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol (Berl) 1997;93:109-117.
11. Plate KH, Risau W. Angiogenesis in malignant gliomas. Glia 1995; 15:339-347.
12. Provias J, Claffey K, delAguila L et al. Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery 1997;40:1016-1026.
13. Goldman CK, Bharara S, Palmer CA, et al. Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression. Neurosurgery 1997;40:1269-1277.
14. Bharara S, Goldman CK, Palmer C, Vitek J, Gillespie GY. Vascular endothelial growth factor expression correlates with cerebral edema in meningiomas (Meeting abstract). Proc Annu Meet Am Assoc Cancer Res 1996;37:A399.
15. Stratmann A, Machein MR, Plate KH. Anti-angiogenic gene therapy of malignant glioma. Acta Neurochir Suppl (Wien) 1997;68:105-110.
16. Martiny-Baron G, Marme D. VEGF-mediated tumour angiogenesis: a new target for cancer therapy. Curr Opin Biotechnol 1995;6:675-680.
17. Aronen HJ, Glass J, Pardo FS. Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility. Acta Radiol 1995;36:520-528.
18. Brasch R, Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997;7:68-74.
19. Grubb R, Raichle M, Higgins C, Eichling J. Measurement of regional cerebral blood volume by emission tomography. Ann Neurol 1978;4:322-328.
20. Hacklander T, Reichenbach JR, Modder U. Comparison of cerebral blood volume measurements using the T1 and T2* methods in normal human brains and brain tumors. J Comput Assist Tomogr 1997;21:857-866.
21. Dennie J, Mandeville JB, Boxerman JL, et al. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 1998;40:793-799.
22. Donahue K, Pathak A, Rand S, Prost R, Krouwer H. Utility of acquiring vascular blood volume, permeability and morphology information from dynamic susceptibility contrast agent studies in patients with brain tumors. In: Proceedings of the 7th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Philadelphia, 1999. p 149.
23. Kassner A, Annesley D, Zhu XP, et al. Abnormalities of the contrast re-circulation phase in cerebral tumours demonstrated using dynamic susceptibility contrast-enhanced MR imaging: a possible marker of vascular tortuosity. J Magn Reson Imaging (in press).
24. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-1039.
25. Jensen RL. Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review. Surg Neurol 1998;49:189-195: discussion 196.
26. Larsson H, Stubgaard M, Frederiksen J, et al. Quantitation of blood-brain carrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990;16:117-131.
27. Brix G, Semmler W, et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomog 1991;15: 621-628.
28. Tofts PS, Kermode AG. Measurement of the blood brain barrier permeability and leakage space using dynamic MR imaging: fundamental concepts. Magn Reson Med 1991;17:357-367.
29. Tofts P, Berkowitz B, Schnall M. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumours using a permeability model. Magn Reson Med 1995;33:564-568.
30. Bhujwalla ZM, Artemov D, Solaiyappan M. Comparison of vascular volume and permeability for tumors derived from metastatic human breast cancer cells with and without the metastasis suppressor gene nm23. In: Proceedings of the 7th Scientific Meeting of the International Society of Magnetic Resonance, Philadelphia, 1999. p 146.
31. Henderson E, Sykes J, Drost D, Weinmann HJ. Measurement of blood flow, blood volume and capillary permeability in a canine spontaneous breast tumor model using two different contrast agents. In: Proceedings of the 8th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Philadelphia, 1999. p 148.
32. Zhu X, Hawnaur JM, Stringfellow J, et al. Quantification of relative blood volume and endothelium permeability of breast neoplasm using dynamic MR imaging. In: Proceedings of the 7th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Philadelphia, 1999. p 1076.
33. Weisskoff R, Boxerman J, Sorensen A, et al. Simultaneous blood volume and permeability mapping using a single Gd-based contrast injection. In: Proceedings of the 2nd Scientific Meeting of the International Society of Magnetic Resonance in Medicine, San Francisco, 1994. p 279.
34. Hacklander T, Reichenbach JR, Hofer M, Modder U. Measurement of cerebral blood volume via the relaxing effect of low dose gadopentate dimeglumine during bolus transit. AJNR 1996;17:821-830.
35. Li KL, Tessier JJL, Waterton JC, et al. Accurate measurement of arterial input function (AIF) using a 3D T1 gradient echo imaging method. In: Proceedings of the 7th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Philadelphia, 1999. p 573.
36. Zhu X, Li K-L, Waterton J, et al. 3D T1 mapping by means of fast field echo technique. In: Proceedings of the 7th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Philadelphia, 1999. p 2143.
37. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-265.
38. Weisskoff RM, Chesler D, Boxerman JL, Rosen BR. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time? Magn Reson Med 1993;29:553-558.
39. Parker G, Suckling J, Tanner S. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging 1997;7:564-574.
40. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
41. Bruening R, Kwong KK, Vevea MJ, et al. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting. AJNR 1996;17:831-840.
42. Maeda M, Itoh S, Kimura H, et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology 1993;189:233-238.
43. Budinger TF, Huesman RH. Ten precepts for quantitative data acquisition and analysis. Circulation 1985;72(suppl (IV):IV53-IV62.
44. Ostergaard L, Hochberg FH, Rabinov JD, et al. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg 1999; 90:300-305.
45. Li KL, Zhu XP, Waterton J, Jackson A. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumours. J Magn Reson Imaging (in press).
46. Lev MH, Kulke SF, Sorensen AG, et al. Contrast-to-noise ratio in functional MRI of relative cerebral blood volume with sprodiamide injection. J Magn Reson Imaging 1997;7:523-527.
47. Ostergaard L, Sorensen AG, Kwong KK, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn Reson Med 1996;36:726-736.
48. Leach M. Assessing contrast enhanced MRI as a method of screening women at genetic risk of breast cancer: study design, methodology and analysis. In: Proceedings of the 6th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Sidney, 1997. p 226.
49. Donahue KM, Weisskoff RM, Chesler DA, et al. Improving MR quantification of regional blood volume with intravascular T1 contrast agents: accuracy, precision, and water exchange. Magn Reson Med 1996;36:856-867.
50. Wedeking P, Sotak CH, Telser J, et al. Quantitative dependence of MR signal intensity on tissue concentration of Gd(HP-DO3A) in the nephrectomized rat. Magn Reson Imaging 1992;10:97-108.
51. Tofts PS, Shuter B, Pope JM. Ni-DTPA doped agarose gel - a phantom material for Gd-DTPA enhancement measurements. Magn Reson Imaging 1993;11:125-133.
52. Press GA, Hesselink JR. MR imaging of cerebellopontine angle and internal auditory canal lessions at 1.5T. Cancer 1991;48:2641-2658.
53. Ellinger R, Kremser C, Schocke M, et al. The impact of the arterial input function (AIF) on quantitative evaluation of dynamic susceptibility contrast enhanced MR studies. In: Proceedings of the 6th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Sidney, 1997. p 1207.
54. Parker GJM, Tanner SF, Leach MO. Pitfalls in the measurement of tissue permeability over short time-scales using a low temporal resolution blood input function. In: Proceedings of the 6th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Sidney, 1996. p 1582.
55. Pedevilla M, Stollberger R, Wach P, Ebner F. Influence of capillary flow and first pass effects on determination of tissue permeability. In: Proceedings of the 6th Scientific Meeting of the International Society of Magnetic Resonance, Sidney, 1998. p 1651.
56. Weidner N, Semple J, Welch W, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
57. Jain RK. Determinants of tumor blood flow: a review. Cancer 1991; 48:2641-2658.
58. Hawighorst H, Knapstein PG, Knopp MV, et al. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curve for assessment of tumor angiogenesis and patient survival. Cancer Res 1998;58:3598-3602.
59. Neeman M, Abramovitch R, Schiffenbauer YS, Tempel C. Regulation of angiogenesis by hypoxic stress: from solid tumors to the ovarian follicle. Int J Exp Pathol 1997;78:57-70.